Evaluate the Safety and Efficacy of ADGRE2 CAR-T in Patients With R/R AML
NCT05463640
·
clinicaltrials.gov ↗
PHASE1
Phase
UNKNOWN
Status
20
Enrollment
OTHER
Sponsor class
Conditions
AML
Interventions
BIOLOGICAL:
ADGRE2 CAR-T
Sponsor
Zhejiang University